ARTICLE | Clinical News
MaterniT21 PLUS laboratory-developed test regulatory update
October 29, 2012 7:00 AM UTC
The not-for-profit California Technology Assessment Forum (CTAF) recommended use of Sequenom's MaterniT21 PLUS laboratory-developed test (LDT) to detect prenatal fetal chromosomal anomalies. Specifica...